Direct alteration of a specific inhibitory circuit of the hippocampus by antidepressants

Journal of Neuroscience

Volumn 32, Issue 47, 2012, Pages 16616-16628

  Méndez, Pablo ^a,c   Pazienti, Antonio ^a   Szabó, Gabor ^b   Bacci, Alberto ^a  

^a EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CANNABINOID 1 RECEPTOR; FLUOXETINE; IMIPRAMINE;

4 AMINOBUTYRIC ACID RELEASE; AMINE TRANSPORT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EVOKED RESPONSE; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; GABAERGIC TRANSMISSION; GAMMA RHYTHM; HIPPOCAMPAL CA1 REGION; HISTOLOGY; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; MALE; MOUSE; NERVE CELL NETWORK; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SPIKE WAVE; SYNAPTIC INHIBITION;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BIOGENIC MONOAMINES; CA1 REGION, HIPPOCAMPAL; DATA INTERPRETATION, STATISTICAL; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; FLUOXETINE; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; IMIPRAMINE; INHIBITION (PSYCHOLOGY); INTERNEURONS; MALE; NERVE NET; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SEROTONIN UPTAKE INHIBITORS; SYNAPTIC TRANSMISSION;

EID: 84870002135     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1720-12.2012     Document Type: Article

References (56)

1. Atallah BV, Scanziani M (2009) Instantaneous modulation of gamma oscillation frequency by balancing excitation with inhibition. Neuron 62:566-577. CrossRef Medline
2. Benes FM, Berretta S (2001) GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25:1-27. CrossRef Medline
3. Berrocoso E, Sánchez-Blazquez P, Garzón J, Mico JA (2009) Opiates as antidepressants. Curr Pharm Des 15:1612-1622. CrossRef Medline
4. Buzsáki G, Draguhn A (2004) Neuronal oscillations in cortical networks. Science 304:1926-1929. CrossRef Medline
5. Cardin JA, Carlén M, Meletis K, Knoblich U, Zhang F, Deisseroth K, Tsai LH, Moore CI (2009) Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 459:663-667. CrossRef Medline
6. Charney DS (1998) Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry 59 [Suppl 14]:11-14.
7. Croarkin PE, Levinson AJ, Daskalakis ZJ (2011) Evidence for GABAergic inhibitory deficits in major depressive disorder. Neurosci Biobehav Rev 35:818-825. CrossRef Medline
8. Daw MI, Tricoire L, Erdelyi F, Szabo G, McBain CJ (2009) Asynchronous transmitter release from cholecystokinin-containing inhibitory interneurons is widespread and target-cell independent. J Neurosci 29:11112-11122. CrossRef Medline
9. Fink KB, Göthert M (2007) 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 59:360-417. CrossRef Medline
10. Freund TF, Buzsáki G (1996) Interneurons of the hippocampus. Hippocampus 6:347-470. Medline
11. Freund TF, Katona I (2007) Perisomatic inhibition. Neuron 56:33-42. CrossRef Medline
12. Galarreta M, Erdélyi F, Szabó G, Hestrin S (2008) Cannabinoid sensitivity and synaptic properties of 2 GABAergic networks in the neocortex. Cereb Cortex 18:2296-2305. CrossRef Medline
13. Glickfeld LL, Scanziani M (2006) Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells. Nat Neurosci 9:807-815. CrossRef Medline
14. Glickfeld LL, Atallah BV, Scanziani M (2008) Complementary modulation of somatic inhibition by opioids and cannabinoids. J Neurosci 28:1824-1832. CrossRef Medline
15. Hájos N, Pálhalmi J, Mann EO, Németh B, Paulsen O, Freund TF (2004) Spike timing of distinct types of GABAergic interneuron during hippocampal gamma oscillations in vitro. J Neurosci 24:9127-9137. CrossRef Medline
16. Hefft S, Jonas P (2005) Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse. Nat Neurosci 8:1319-1328. CrossRef Medline
17. Henry ME, Schmidt ME, Hennen J, Villafuerte RA, Butman ML, Tran P, Kerner LT, Cohen B, Renshaw PF (2005) A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: a 19-F MRS study. Neuropsychopharmacology 30:1576-1583. CrossRef Medline
18. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M (2009) Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89:309-380. CrossRef Medline
19. Klausberger T, Somogyi P (2008) Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science 321:53-57. CrossRef Medline
20. Kobayashi K, Ikeda Y, Haneda E, Suzuki H (2008) Chronic fluoxetine bidirectionally modulates potentiating effects of serotonin on the hippocampal mossy fiber synaptic transmission. J Neurosci 28:6272-6280. CrossRef Medline
21. Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455:894-902. CrossRef Medline
22. Krishnan V, Nestler EJ (2010) Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry 167:1305-1320. CrossRef Medline
23. Kudina TA, Sudnitsyn VV, Kutyreva EV, Kichigina VF (2004) The serotonin reuptake inhibitor fluoxetine suppresses theta oscillations in the electroencephalogram of the rabbit hippocampus. Neurosci Behav Physiol 34:929-933. CrossRef Medline
24. Lacasse JR, Leo J (2005) Serotonin and depression: a disconnect between the advertisements and the scientific literature. PLoS Med 2:e392. CrossRef Medline
25. Lee PS, Chen YS, Hsieh JC, Su TP, Chen LF (2010) Distinct neuronal oscillatory responses between patients with bipolar and unipolar disorders: a magnetoencephalographic study. J Affect Disord 123:270-275. CrossRef Medline
26. Levitt P, Eagleson KL, Powell EM (2004) Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci 27:400-406. CrossRef Medline
27. Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312-324. CrossRef Medline
28. Linkenkaer-Hansen K, Monto S, Rytsälä H, Suominen K, Isomets Ä E, Kähkönen S (2005) Breakdown of long-range temporal correlations in theta oscillations in patients with major depressive disorder. J Neurosci 25: 10131-10137. CrossRef Medline
29. López-Muñoz F, Alamo C (2009) Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des 15:1563-1586. CrossRef Medline
30. Luscher B, Shen Q, Sahir N (2011) The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 16:383406. Medline
31. Maguire J, Mody I (2008) GABA(A)R plasticity during pregnancy: relevance to postpartum depression. Neuron 59:207-213. CrossRef Medline
32. Mann EO, Mody I (2010) Control of hippocampal gamma oscillation frequency by tonic inhibition and excitation of interneurons. Nat Neurosci 13:205-212. CrossRef Medline
33. Manseau F, Marinelli S, Méndez P, Schwaller B, Prince DA, Huguenard JR, Bacci A (2010) Desynchronization of neocortical networks by asynchronous release of GABA at autaptic and synaptic contacts from fast-spiking interneurons. PLoS Biol 8:e1000492. Medline
34. Maya Vetencourt JF, Sale A, Viegi A, Baroncelli L, De Pasquale R, O'Leary OF, Castrén E, Maffei L (2008) The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 320:385-388. CrossRef Medline
35. Möhler H (2012) The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 62:42-53. CrossRef Medline
36. Orekhova EV, Stroganova TA, Nygren G, Tsetlin MM, Posikera IN, Gillberg C, Elam M (2007) Excess of high frequency electroencephalogram oscillations in boys with autism. Biol Psychiatry 62:1022-1029. CrossRef Medline
37. Puig MV, Watakabe A, Ushimaru M, Yamamori T, Kawaguchi Y (2010) Serotonin modulates fast-spiking interneuron and synchronous activity in the rat prefrontal cortex through 5-HT1A and 5-HT2A receptors. J Neurosci 30:2211-2222. CrossRef Medline
38. A synaptic currents in the rat substantia nigra pars reticulata. J Neurosci 18:2009-2016. Medline
39. Rajkowska G, O'Dwyer G, Teleki Z, Stockmeier CA, Miguel-Hidalgo JJ (2007) GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 32:471-482. CrossRef Medline
40. Robinson RT, Drafts BC, Fisher JL (2003) Fluoxetine increases GABA(A) receptor activity through a novel modulatory site. J Pharmacol Exp Ther 304:978-984. Medline
41. Rodríguez-Moreno A, López-García JC, Lerma J (2000) Two populations of kainate receptors with separate signaling mechanisms in hippocampal interneurons. Proc Natl Acad Sci U S A 97:1293-1298. CrossRef Medline
42. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, Berman RM, Charney DS, Krystal JH (1999) Reduced cortical gammaaminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56:1043-1047. CrossRef Medline
43. Sanacora G, Mason GF, Rothman DL, Krystal JH (2002) Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 159:663-665. CrossRef Medline
44. Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF (2004) Subtype-specific alterations of gammaaminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61:705-713. CrossRef Medline
45. Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509-522. Medline
46. Schulman JJ, Cancro R, Lowe S, Lu F, Walton KD, Llinás RR (2011) Imaging of thalamocortical dysrhythmia in neuropsychiatry. Front Hum Neurosci 5:69. Medline
47. Seamans JK, Gorelova N, Durstewitz D, Yang CR (2001) Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 21:3628-3638. Medline
48. Smith KS, Rudolph U (2012) Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes. Neuropharmacology 62:54-62. CrossRef Medline
49. Sohal VS, Zhang F, Yizhar O, Deisseroth K (2009) Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459: 698-702. CrossRef Medline
50. Sugita S, Kobayashi A, Suzuki S, Yoshida T, Nakazawa K (1989) Correlative changes of serotonin and catecholamines with pharmacokinetic alterations of imipramine in rat brain. Eur J Pharmacol 165:191-198. CrossRef Medline
51. Tunnicliff G, Schindler NL, Crites GJ, Goldenberg R, Yochum A, Malatynska E (1999) The GABA(A) receptor complex as a target for fluoxetine action Neurochem Res 24:1271-1276.
52. Varga V, Losonczy A, Zemelman BV, Borhegyi Z, Nyiri G, Domonkos A, Hangya B, Holderith N, Magee JC, Freund TF (2009) Fast synaptic subcortical control of hippocampal circuits. Science 326:449-453. CrossRef Medline
53. Wang XJ (2010) Neurophysiological and computational principles of cortical rhythms in cognition. Physiol Rev 90:1195-1268. CrossRef Medline
54. Wilson RI, Kunos G, Nicoll RA (2001) Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31:453-462. CrossRef Medline
55. Ye ZY, Zhou KQ, Xu TL, Zhou JN (2008) Fluoxetine potentiates GABAergic IPSCs in rat hippocampal neurons. Neurosci Lett 442:24-29. CrossRef Medline
56. Zhang L, Rasenick MM (2010) Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporterindependent action of this antidepressant compound. J Pharmacol Exp Ther 332:977-984. CrossRef Medline